Vanderbilt Medical Center - VanderbiltHealth.com
 
 

Blood "signatures" enhance cancer therapy

A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has discovered a "signature" of proteins in the blood that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies. Such targeted cancer therapies are the newest generation of anti-cancer drugs. Click here to read more »

Publications from Vanderbilt Medical Center:
The Reporter   House Organ      VU Medicine

Deep Brain Stimulation: Enhancing the lives of Parkinson's patients

Copyright © 2008 by Vanderbilt Medical Center    |    (615) 322-5000    |    1211 Medical Center Drive    |    Nashville, TN 37232
Vanderbilt University is committed to principles of equal opportunity and affirmative action.